These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35164777)

  • 1. How to set the agenda for hepatitis C: a theory-driven policy analysis.
    Kind J; Maeschli B; Bruggmann P
    Health Res Policy Syst; 2022 Feb; 20(1):20. PubMed ID: 35164777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon's multiple streams framework.
    Behzadifar M; Gorji HA; Rezapour A; Bragazzi NL
    Health Res Policy Syst; 2019 Mar; 17(1):30. PubMed ID: 30917837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis.
    Behzadifar M; Gorji HA; Rezapour A; Rezvanian A; Bragazzi NL; Vatankhah S
    Health Res Policy Syst; 2019 Apr; 17(1):42. PubMed ID: 30992014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaling up population health interventions from decision to sustainability - a window of opportunity? A qualitative view from policy-makers.
    Lee K; van Nassau F; Grunseit A; Conte K; Milat A; Wolfenden L; Bauman A
    Health Res Policy Syst; 2020 Oct; 18(1):118. PubMed ID: 33036633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putting newborn hearing screening on the political agenda in Belgium: local initiatives toward a community programme - a qualitative study.
    Vos B; Lagasse R; Levêque A
    Health Res Policy Syst; 2014 Jul; 12():32. PubMed ID: 24986647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
    Müllhaupt B; Bruggmann P; Bihl F; Blach S; Lavanchy D; Razavi H; Robbins Scott S; Semela D; Negro F
    PLoS One; 2018; 13(12):e0209374. PubMed ID: 30596701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the process of establishing a food and nutrition policy: the case of Slovenia.
    Kugelberg S; Jönsson K; Yngve A
    Health Policy; 2012 Sep; 107(1):91-7. PubMed ID: 22771079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Swiss Hepatitis Strategy as a model for facing future health policy challenges.
    Blindenbacher R; Maeschli B; Bruggmann P
    Health Policy; 2019 Jul; 123(7):681-687. PubMed ID: 31128856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of policy actors and contextual factors in policy agenda setting and formulation: maternal fee exemption policies in Ghana over four and a half decades.
    Koduah A; van Dijk H; Agyepong IA
    Health Res Policy Syst; 2015 May; 13():27. PubMed ID: 26022699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.
    Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J
    Int J Drug Policy; 2019 Apr; 66():87-93. PubMed ID: 30743093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Egypt's Ambitious Strategy to Eliminate Hepatitis C Virus: A Case Study.
    Hassanin A; Kamel S; Waked I; Fort M
    Glob Health Sci Pract; 2021 Mar; 9(1):187-200. PubMed ID: 33795369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges.
    Behzadifar M; Azari S; Gorji HA; Martini M; Bragazzi NL
    J Prev Med Hyg; 2020 Mar; 61(1):E109-E118. PubMed ID: 32490276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends of the Global Hepatitis C Disease Burden: Strategies to Achieve Elimination.
    Brunner N; Bruggmann P
    J Prev Med Public Health; 2021 Jul; 54(4):251-258. PubMed ID: 34370938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study.
    Agosti-Gonzalez R; Falcato L; Grischott T; Senn O; Bruggmann P
    Swiss Med Wkly; 2023 Jun; 153():40085. PubMed ID: 37410941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the contributions of an urban population health initiative to shift political priority towards cardiovascular health: three case studies from Brazil, Mongolia and Senegal.
    Saric J; Aerts A; Anne M; Barboza J; Boch J; Dashdorj N; McGhie DV; Santana A; Shellaby JT; Rollemberg SMS; Silveira M; Steinmann P; Cobos D
    BMC Health Serv Res; 2024 Jan; 24(1):16. PubMed ID: 38178108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort.
    Bregenzer A; Bruggmann P; Castro E; Moriggia A; Rothen M; Thurnheer MC; Vernazza P; Scheidegger C
    Swiss Med Wkly; 2021 Mar; 151():w20460. PubMed ID: 33705563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C in a psychiatric setting: A forgotten reservoir?].
    Rolland B; Bailly F; Cutarella C; Drevon O; Carrieri P; Darque A; Hallouche N; Maptue N; Pol S; Llorca PM; Lang JP
    Encephale; 2021 Apr; 47(2):181-184. PubMed ID: 32473777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal cancer prevention policies in Iran: A policy analysis of agenda-setting using Kingdon's multiple streams.
    Kabiri N; Khodayari-Zarnaq R; Khoshbaten M; Arab-Zozani M; Janati A
    J Cancer Policy; 2021 Mar; 27():100265. PubMed ID: 35559940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public health policy and walking in England-analysis of the 2008 'policy window'.
    Milton K; Grix J
    BMC Public Health; 2015 Jul; 15():614. PubMed ID: 26143071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Setting the policy agenda for the treatment of substance use disorders in Iran.
    Mirzaei S; Yazdi-Feyzabadi V; Mehrolhassani MH; Nakhaee N; Oroomiei N
    Harm Reduct J; 2022 Mar; 19(1):27. PubMed ID: 35292060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.